StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
43
This year
3
Publishing Date
2024 - 02 - 22
1
2024 - 02 - 12
1
2024 - 02 - 06
1
2023 - 12 - 08
1
2023 - 09 - 12
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 08
1
2023 - 06 - 01
1
2023 - 04 - 07
1
2023 - 04 - 04
1
2023 - 03 - 06
1
2023 - 02 - 13
1
2023 - 01 - 19
1
2022 - 11 - 28
1
2022 - 11 - 10
1
2022 - 08 - 19
1
2022 - 08 - 03
1
2022 - 07 - 13
1
2022 - 07 - 01
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 03
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 03 - 25
1
2022 - 03 - 21
1
2022 - 03 - 16
2
2022 - 03 - 08
1
2022 - 02 - 17
1
2022 - 02 - 14
1
2021 - 12 - 21
1
2021 - 11 - 12
1
2021 - 10 - 07
1
2021 - 10 - 04
1
2021 - 09 - 16
1
2021 - 08 - 25
2
2021 - 08 - 05
2
2021 - 07 - 30
1
2021 - 04 - 14
1
Sector
Health technology
43
Manufacturing
10
N/a
1
Process industries
1
Technology services
1
Tags
Alzheimer's
1
Alzheimer’s
1
Approval
3
Biotech
1
Biotech-bay
5
Biotechnology
1
Blood
1
Business
2
Cabometyx
2
Cancer
8
Cel
1
Cell
1
Cell carcinoma
5
Ces
1
Chmp
1
Clinical-trials-phase-iii
2
Companies
1
Depression
1
Diagnostics
1
Disease
3
Distribution
1
Drug
4
Ema
2
Europe
1
Expansion
1
Financial results
2
Global
11
Growing
1
Growth
6
Life
1
Liver
1
Lung
1
Lupus
1
Market
20
Metabolic
1
N/a
34
Nivolumab
4
Opdivo
2
Orphan drug
1
Positive
1
Potential
1
Product-news
1
Reach
3
Renal
5
Report
12
Research
3
Results
2
Set
1
Study
1
System
1
Therapeutics
7
Therapy
3
Treat
1
Treatment
8
Trial
2
Entities
Abbott laboratories
10
Abbvie inc.
31
Adma biologics inc
4
Adverum biotechnologies, inc.
2
Agios pharmaceuticals, inc.
2
Alnylam pharmaceuticals, inc.
2
Altria group
2
Amgen inc.
23
Amicus therapeutics, inc.
2
Arcturus therapeutics holdings inc.
26
Arrowhead pharmaceuticals, inc.
12
Astellas pharma inc
12
Astrazeneca plc
29
Avalonbay communities, inc.
2
Bausch health companies inc.
7
Baxter international inc.
5
Biocryst pharmaceuticals, inc.
2
Biogen inc.
6
Bristol-myers squibb company
43
Catalent, inc.
3
Centogene n.v.
5
Codexis, inc.
3
Csl ltd
4
Eli lilly and company
42
Exelixis, inc.
27
Genmab a/s
3
Gilead sciences, inc.
15
Glaxosmithkline plc
34
Global blood therapeutics, inc.
3
Grifols, s.a.
6
Hutchison china meditech limited
7
Immunogen, inc.
3
Incyte corporation
16
Jazz pharmaceuticals plc
6
Johnson & johnson
82
Karyopharm therapeutics inc.
7
Logicbio therapeutics, inc.
4
Macrogenics, inc.
4
Mallinckrodt plc
4
Moderna, inc.
5
Morphosys ag
13
Nektar therapeutics
3
Neurocrine biosciences, inc.
9
Novartis ag
58
Novavax, inc.
4
Novo nordisk a/s
15
Orange
4
Ovid therapeutics inc.
6
Pfizer, inc.
23
Regeneron pharmaceuticals, inc.
6
Sanofi
60
Takeda pharmaceutical company limited
421
Teva pharmaceutical industries limited
5
Teva pharmaceutical industries ltd
20
Thermo fisher scientific inc
7
Ucb s.a.
8
Vericel corporation
3
Vertex pharmaceuticals incorporated
4
Viatris inc.
7
Xencor, inc.
12
Symbols
ABBV
88
ABT
26
ADCT
13
ADXS
8
AGIO
12
ALB
8
ALNY
11
ALPMF
11
ALPMY
11
AMGN
86
AVEO
19
AYLA
12
AZN
61
AZNCF
53
BCRX
13
BGNE
12
BHC
10
BIIB
11
BLUE
8
BMY
662
BOLT
7
BPMC
19
BSX
6
CLVS
20
EPZM
18
EXEL
29
GILD
45
GLAXF
50
GMAB
6
GNMSF
6
GSK
67
ILMN
10
INCY
24
INTS
12
JNJ
91
KPTI
19
LLY
106
MRTX
10
NKTR
7
NVO
7
NVS
103
NVSEF
82
OMER
13
OTIC
13
PFE
61
REGN
30
RIGL
11
SNY
119
SNYNF
70
TAK
43
TEVA
8
TEVJF
37
TPTX
7
TSVT
11
UCBJF
8
UCBJY
8
VSTM
11
VTRS
15
XERS
10
YMAB
18
Exchanges
Nasdaq
43
Nyse
43
Crawled Date
2024 - 02 - 22
1
2024 - 02 - 12
1
2024 - 02 - 07
1
2023 - 12 - 08
1
2023 - 09 - 12
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 08
1
2023 - 06 - 01
1
2023 - 04 - 07
1
2023 - 04 - 04
1
2023 - 03 - 06
1
2023 - 02 - 14
1
2023 - 01 - 19
1
2022 - 11 - 28
1
2022 - 11 - 10
1
2022 - 08 - 19
1
2022 - 08 - 03
1
2022 - 07 - 13
1
2022 - 07 - 01
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 03
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 03 - 25
1
2022 - 03 - 21
1
2022 - 03 - 16
2
2022 - 03 - 08
1
2022 - 02 - 18
1
2022 - 02 - 14
1
2021 - 12 - 21
1
2021 - 11 - 12
1
2021 - 10 - 07
1
2021 - 10 - 04
1
2021 - 09 - 16
1
2021 - 08 - 25
2
2021 - 08 - 05
2
2021 - 07 - 30
1
2021 - 04 - 15
1
Crawled Time
00:00
4
01:00
2
02:00
2
07:00
1
08:00
1
09:00
1
10:00
2
11:00
3
13:00
1
13:20
1
14:00
3
14:30
1
15:15
1
16:00
1
17:00
1
18:00
2
19:00
2
20:00
2
21:00
2
22:00
5
23:00
5
Source
www.biospace.com
9
www.prnewswire.com
34
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Bristol-myers squibb company
symbols :
Tak
save search
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
6.54%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
25.87%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-16.01%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.24%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.58%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.13%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.33%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.44%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.88%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-6.54%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.41%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.44%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.58%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.83%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-25.59%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.63%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-8.91%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-8.68%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.11
0.47%
0.47%
330K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-10.02%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-13.72%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
37.02%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-14.23%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.13%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.93%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
6.49%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.95%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.43%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.09%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.19%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-14.12%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-16.18%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-22.28%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-23.82%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.61%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
28.63%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.97%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.07%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
27.99%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.71%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
11.75%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.46%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.29%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.35%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
Global Antibodies Market Set to Soar, Projected to Reach $524.8 Billion by 2030 with a CAGR of 12.9%
Published:
2023-09-12
(Crawled : 23:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.3%
|
O:
-1.8%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.82%
|
O:
0.63%
H:
0.5%
C:
0.31%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.56%
|
O:
1.05%
H:
0.73%
C:
0.14%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-19.82%
|
O:
0.02%
H:
0.55%
C:
-1.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
10.65%
|
O:
0.05%
H:
0.0%
C:
0.0%
RARE
|
News
F
|
$42.37
-2.33%
-2.38%
680K
|
Health Technology
|
6.52%
|
O:
-0.02%
H:
1.4%
C:
-1.07%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.91%
|
O:
-0.99%
H:
0.0%
C:
0.0%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
123.39%
|
O:
0.0%
H:
0.63%
C:
-1.98%
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
97.99%
|
O:
-0.34%
H:
0.51%
C:
-8.5%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-17.76%
|
O:
0.0%
H:
0.53%
C:
-1.76%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-24.49%
|
O:
0.07%
H:
0.53%
C:
-1.05%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
1.78%
|
O:
-0.37%
H:
0.34%
C:
-0.81%
reach
global
set
market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.61%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-31.09%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.46%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-11.42%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.18%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
65.82%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.45%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-4.83%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published:
2023-06-08
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-7.89%
|
O:
0.07%
H:
0.0%
C:
-1.7%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.25%
|
O:
1.32%
H:
0.0%
C:
-0.62%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.27%
|
O:
-0.62%
H:
0.88%
C:
0.81%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.5%
|
O:
1.26%
H:
1.08%
C:
0.91%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
15.25%
|
O:
0.41%
H:
0.68%
C:
0.64%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
72.05%
|
O:
-0.11%
H:
2.66%
C:
2.24%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.87%
|
O:
0.28%
H:
0.42%
C:
-0.05%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-21.24%
|
O:
0.39%
H:
0.15%
C:
-0.79%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-6.88%
|
O:
-0.23%
H:
1.83%
C:
1.52%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
19.74%
|
O:
0.0%
H:
0.28%
C:
-0.23%
metabolic
report
cancer
global
therapeutics
growth
market
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published:
2023-06-01
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.59%
|
O:
-0.56%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-8.39%
|
O:
-0.74%
H:
1.4%
C:
0.35%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.61%
|
O:
0.99%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.24%
|
O:
1.32%
H:
0.31%
C:
0.12%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.14%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-21.17%
|
O:
-1.84%
H:
1.62%
C:
1.33%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.15%
|
O:
1.03%
H:
0.84%
C:
0.82%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.32%
|
O:
0.37%
H:
1.34%
C:
1.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-9.41%
|
O:
1.05%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-6.28%
|
O:
0.11%
H:
0.69%
C:
-0.45%
report
global
therapeutics
growth
market
Ulcerative Colitis Drug Global Market Report 2022: Increasing Prevalence of Ulcerative Colitis and Inflammatory Bowel Diseases Bolsters Sector
Published:
2023-04-07
(Crawled : 11:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
drug
report
global
market
Global Depression Treatment Market to 2030: Rising Prevalence of Psychiatric Diseases and Development of Innovative Medications for Treatment-resistant Depression Drives Growth
Published:
2023-04-04
(Crawled : 02:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-20.4%
|
O:
-0.12%
H:
1.55%
C:
1.03%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
114.05%
|
O:
0.38%
H:
1.97%
C:
0.72%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-30.69%
|
O:
0.13%
H:
0.0%
C:
-1.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.36%
|
O:
-0.1%
H:
0.0%
C:
0.0%
depression
treatment
global
growth
market
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published:
2023-03-06
(Crawled : 20:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-10.86%
|
O:
-0.86%
H:
0.33%
C:
0.33%
CSLLY
|
$86.918
3.3%
60K
|
n/a
|
-11.33%
|
O:
-0.02%
H:
0.54%
C:
-1.7%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.92%
|
O:
-2.57%
H:
1.62%
C:
1.62%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-4.57%
|
O:
0.41%
H:
0.39%
C:
-2.14%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
33.0%
|
O:
-1.21%
H:
0.43%
C:
-3.58%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-15.92%
|
O:
0.83%
H:
0.06%
C:
-1.2%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-18.72%
|
O:
0.76%
H:
1.91%
C:
1.26%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
14.95%
|
O:
0.32%
H:
0.17%
C:
-1.53%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
135.38%
|
O:
0.01%
H:
0.42%
C:
-2.62%
CTLT
|
$55.48
-0.57%
-0.4%
1.6M
|
Health Technology
|
-21.81%
|
O:
0.11%
H:
0.53%
C:
-5.05%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-29.9%
|
O:
0.41%
H:
0.04%
C:
-1.71%
ALB
|
$112.15
0.31%
-0.13%
2M
|
Process Industries
|
-55.43%
|
O:
-0.95%
H:
1.02%
C:
-2.19%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
6.36%
|
O:
0.19%
H:
0.06%
C:
-1.7%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.65%
|
O:
0.65%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-17.52%
|
O:
0.23%
H:
0.0%
C:
-1.25%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-27.79%
|
O:
0.28%
H:
0.0%
C:
-2.26%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
5.74%
|
O:
0.9%
H:
0.28%
C:
-1.3%
global
report
market
Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Shows Durable Survival with Over Three Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma
Published:
2023-02-13
(Crawled : 00:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.07%
|
O:
-1.37%
H:
0.69%
C:
0.51%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.1%
|
O:
0.03%
H:
1.69%
C:
1.32%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
31.2%
|
O:
-0.68%
H:
1.66%
C:
1.49%
opdivo
renal
trial
cell carcinoma
nivolumab
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.14%
|
O:
0.69%
H:
0.0%
C:
-1.52%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.53%
|
O:
-0.31%
H:
1.15%
C:
0.68%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-10.9%
|
O:
0.13%
H:
0.65%
C:
0.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.0%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.61%
|
O:
-0.43%
H:
1.33%
C:
0.3%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
12.53%
|
O:
0.17%
H:
1.36%
C:
1.02%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
113.28%
|
O:
0.1%
H:
0.97%
C:
-0.37%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.05%
|
O:
0.29%
H:
2.1%
C:
1.94%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
10.7%
|
O:
-0.17%
H:
1.07%
C:
-0.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.54%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-20.11%
|
O:
0.51%
H:
0.49%
C:
-0.65%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
0.21%
|
O:
-0.9%
H:
0.58%
C:
0.01%
global
report
growth
market
Natural Killer (NK) Cell Therapeutics Market to Perceive Healthy CAGR of 40.9% by 2029, Size, Share, Trends, Demand, Opportunities, Challenges and Competitive Analysis
Published:
2022-11-28
(Crawled : 07:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-9.81%
|
O:
-0.62%
H:
1.04%
C:
0.41%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-39.05%
|
O:
0.05%
H:
0.53%
C:
-0.18%
NKTX
|
$7.26
-6.8%
-7.3%
730K
|
Health Technology
|
-9.34%
|
O:
-0.46%
H:
2.09%
C:
-6.26%
NKTR
|
News
|
$1.265
-4.17%
-4.35%
4.7M
|
Health Technology
|
-58.33%
|
O:
-0.62%
H:
1.09%
C:
-3.73%
therapeutics
market
Lymphoma Treatment Global Market to Reach $18.5 Billion by 2027 at a CAGR of 8.89%
Published:
2022-11-10
(Crawled : 13:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-0.53%
|
O:
2.34%
H:
2.51%
C:
2.29%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.77%
|
O:
0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
106.67%
|
O:
1.09%
H:
0.48%
C:
0.4%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-39.46%
|
O:
1.22%
H:
0.01%
C:
-1.7%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
6.98%
|
O:
3.59%
H:
1.37%
C:
1.16%
treatment
global
market
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published:
2022-08-19
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.94%
|
O:
3.04%
H:
0.12%
C:
-2.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.26%
|
O:
-2.05%
H:
0.29%
C:
0.07%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.67%
|
O:
0.54%
H:
1.24%
C:
0.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-34.86%
|
O:
0.01%
H:
2.09%
C:
1.58%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
44.23%
|
O:
-0.62%
H:
0.57%
C:
-0.42%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.64%
|
O:
-0.25%
H:
1.19%
C:
0.49%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.65%
|
O:
0.78%
H:
0.49%
C:
0.22%
study
market
Global Cancer Therapies Market Report 2022: Market to Reach $209.2 Billion by 2026 - Industry Focuses on New Approaches to Treat Cancer
Published:
2022-08-03
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.46%
|
O:
-1.22%
H:
1.8%
C:
1.8%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.84%
|
O:
2.52%
H:
0.0%
C:
-0.19%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
28.56%
|
O:
-2.88%
H:
0.0%
C:
-0.21%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-5.33%
|
O:
-0.29%
H:
0.72%
C:
0.58%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.02%
|
O:
0.08%
H:
0.29%
C:
-0.08%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.69%
|
O:
0.2%
H:
0.44%
C:
0.24%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.0%
|
O:
1.4%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.99%
|
O:
0.27%
H:
0.1%
C:
-0.81%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
139.23%
|
O:
-1.16%
H:
0.02%
C:
-1.42%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.83%
|
O:
-0.27%
H:
0.22%
C:
-0.92%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.51%
|
O:
1.13%
H:
0.35%
C:
0.35%
global
report
cancer
market
Global Crohn's Disease Treatment Market to Surpass US$ 15.17 Billion by 2030 - Coherent Market Insights
Published:
2022-07-13
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-6.51%
|
O:
-1.46%
H:
0.09%
C:
0.09%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
35.22%
|
O:
-1.35%
H:
0.4%
C:
0.27%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.59%
|
O:
-0.7%
H:
0.21%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
12.13%
|
O:
-1.04%
H:
0.62%
C:
0.55%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
132.83%
|
O:
-1.53%
H:
3.22%
C:
2.94%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-35.19%
|
O:
-1.19%
H:
0.66%
C:
0.5%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
8.55%
|
O:
-2.18%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.1%
|
O:
-1.27%
H:
0.0%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
7.22%
|
O:
-0.84%
H:
0.73%
C:
0.23%
treatment
disease
market
Worldwide Natural Killer Cells Therapeutics Industry to 2027 - Featuring Fate Therapeutics, Fortress Biotech and Ziopharm Oncology Among Others
Published:
2022-07-01
(Crawled : 20:00)
- prnewswire.com
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
biotech
therapeutics
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.